BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25301933)

  • 1. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.
    Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
    Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
    Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
    Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
    Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first reported case of a deletion of the entire RPGR gene in a family with X-linked retinitis pigmentosa.
    Mihailovic N; Schimpf-Linzenbold S; Sattler I; Eter N; Heiduschka P
    Ophthalmic Genet; 2022 Oct; 43(5):679-684. PubMed ID: 35652150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of X-linked retinitis pigmentosa in three Swedish families with newly identified mutations in the RP2 and RPGR-ORF15 genes.
    Andréasson S; Breuer DK; Eksandh L; Ponjavic V; Frennesson C; Hiriyanna S; Filippova E; Yashar BM; Swaroop A
    Ophthalmic Genet; 2003 Dec; 24(4):215-23. PubMed ID: 14566651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish model for the genetic basis of X-linked retinitis pigmentosa.
    Raghupathy RK; McCulloch DL; Akhtar S; Al-mubrad TM; Shu X
    Zebrafish; 2013 Mar; 10(1):62-9. PubMed ID: 23536988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic high myopia in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene.
    Sanchez Tocino H; Diez Montero C; Villanueva Gómez A; Lobo Valentin R; Montero-Moreno JA
    Ophthalmic Genet; 2019 Apr; 40(2):170-176. PubMed ID: 31033374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa.
    Churchill JD; Bowne SJ; Sullivan LS; Lewis RA; Wheaton DK; Birch DG; Branham KE; Heckenlively JR; Daiger SP
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1411-6. PubMed ID: 23372056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype in two families with RP3 associated with RPGR mutations.
    Lorenz B; Andrassi M; Kretschmann U
    Ophthalmic Genet; 2003 Jun; 24(2):89-101. PubMed ID: 12789573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15.
    Bader I; Brandau O; Achatz H; Apfelstedt-Sylla E; Hergersberg M; Lorenz B; Wissinger B; Wittwer B; Rudolph G; Meindl A; Meitinger T
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1458-63. PubMed ID: 12657579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel RPGR (retinitis pigmentosa GTPase regulator) mutations in a subset of X-linked retinitis pigmentosa families segregating with the RP3 locus.
    Zito I; Thiselton DL; Gorin MB; Stout JT; Plant C; Bird AC; Bhattacharya SS; Hardcastle AJ
    Hum Genet; 1999; 105(1-2):57-62. PubMed ID: 10480356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR.
    Cehajic-Kapetanovic J; Xue K; Martinez-Fernandez de la Camara C; Nanda A; Davies A; Wood LJ; Salvetti AP; Fischer MD; Aylward JW; Barnard AR; Jolly JK; Luo E; Lujan BJ; Ong T; Girach A; Black GCM; Gregori NZ; Davis JL; Rosa PR; Lotery AJ; Lam BL; Stanga PE; MacLaren RE
    Nat Med; 2020 Mar; 26(3):354-359. PubMed ID: 32094925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15.
    Thompson DA; Khan NW; Othman MI; Chang B; Jia L; Grahek G; Wu Z; Hiriyanna S; Nellissery J; Li T; Khanna H; Colosi P; Swaroop A; Heckenlively JR
    PLoS One; 2012; 7(5):e35865. PubMed ID: 22563472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation.
    Parmeggiani F; Barbaro V; Migliorati A; Raffa P; Nespeca P; De Nadai K; Del Vecchio C; Palù G; Parolin C; Di Iorio E
    Eur J Ophthalmol; 2017 Mar; 27(2):240-248. PubMed ID: 27768226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.